{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:19:08Z","timestamp":1794691148675,"version":"4.9.1"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02130-z","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:49:54Z","timestamp":1762782594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The vessel-to-neuron trigeminovascular hypothesis of migraine pathogenesis \u2013 the \u2018pro\u2019 argument"],"prefix":"10.1186","volume":"26","author":[{"given":"Rune H\u00e4ckert","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2130_CR1","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"2130_CR2","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. New England Journal of Medicine 383:1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327","journal-title":"New England Journal of Medicine"},{"key":"2130_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-024-01718-1","volume":"25","author":"AV Thomsen","year":"2024","unstructured":"Thomsen AV, Ashina H, Al-Khazali HM et al (2024) Clinical features of migraine with aura: a REFORM study. J Headache Pain 25:22. https:\/\/doi.org\/10.1186\/s10194-024-01718-1","journal-title":"J Headache Pain"},{"key":"2130_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0165-6147(92)90097-P","volume":"13","author":"MA Moskowitz","year":"1992","unstructured":"Moskowitz MA (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 13:307\u2013311. https:\/\/doi.org\/10.1016\/0165-6147(92)90097-P","journal-title":"Trends Pharmacol Sci"},{"key":"2130_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M et al (2017) Pathophysiology of Migraine \u2013 A disorder of sensory processing. Physiol Rev 97:553\u2013622. https:\/\/doi.org\/10.1152\/physrev.00034.2015","journal-title":"Physiol Rev"},{"key":"2130_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/ARCHSURG.1940.01210040002001","volume":"41","author":"BS Ray","year":"1940","unstructured":"Ray BS, Wolff HG (1940) Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Archives of Surgery 41:813\u2013856. https:\/\/doi.org\/10.1001\/ARCHSURG.1940.01210040002001","journal-title":"Archives of Surgery"},{"key":"2130_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/ARCHNEURPSYC.1938.02270040093005","volume":"39","author":"JR Graham","year":"1938","unstructured":"Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737\u2013763. https:\/\/doi.org\/10.1001\/ARCHNEURPSYC.1938.02270040093005","journal-title":"Arch Neurol Psychiatry"},{"key":"2130_CR8","doi-asserted-by":"publisher","unstructured":"Leao AAP (1944) Spreading depression of activity in the cerebral cortex. https:\/\/doi.org\/101152\/jn194476359 7:359\u2013390. https:\/\/doi.org\/10.1152\/JN.1944.7.6.359","DOI":"10.1152\/JN.1944.7.6.359"},{"key":"2130_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/brain\/awt320","volume":"137","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Monteith T et al (2014) Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 137:232\u2013241. https:\/\/doi.org\/10.1093\/brain\/awt320","journal-title":"Brain"},{"key":"2130_CR10","doi-asserted-by":"publisher","unstructured":"Schulte LH, May A (2016) The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 139:aww097\u2013aww097.https:\/\/doi.org\/10.1093\/brain\/aww097","DOI":"10.1093\/brain\/aww097"},{"key":"2130_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(79)92692-8","volume":"314","author":"MA Moskowitz","year":"1979","unstructured":"Moskowitz MA, Romero J, Reinhard JF et al (1979) Neurotransmitters and the Fifth Cranial Nerve: Is There a Relation To the Headache Phase of Migraine? The Lancet 314:883\u2013885. https:\/\/doi.org\/10.1016\/S0140-6736(79)92692-8","journal-title":"The Lancet"},{"key":"2130_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP et al (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18:795\u2013804. https:\/\/doi.org\/10.1016\/S1474-4422(19)30185-1","journal-title":"Lancet Neurol"},{"key":"2130_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0006-8993(93)90486-7","volume":"629","author":"H Kaube","year":"1993","unstructured":"Kaube H, Keay KA, Hoskin KL et al (1993) Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629:95\u2013102. https:\/\/doi.org\/10.1016\/0006-8993(93)90486-7","journal-title":"Brain Res"},{"key":"2130_CR14","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1523\/JNEUROSCI.14-06-03725.1994","volume":"14","author":"AM Strassman","year":"1994","unstructured":"Strassman AM, Mineta Y, Vos BP (1994) Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J Neurosci 14:3725\u20133735. https:\/\/doi.org\/10.1523\/JNEUROSCI.14-06-03725.1994","journal-title":"J Neurosci"},{"key":"2130_CR15","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1152\/JN.1998.79.2.964","volume":"79","author":"R Burstein","year":"1998","unstructured":"Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964\u2013982. https:\/\/doi.org\/10.1152\/JN.1998.79.2.964","journal-title":"J Neurophysiol"},{"key":"2130_CR16","doi-asserted-by":"publisher","unstructured":"Lee SH, Hwang SJ, Koh KS et al (2017) Macroscopic innervation of the dura mater covering the middle cranial fossa in humans correlated to neurovascular headache. Front Neuroanat 11. https:\/\/doi.org\/10.3389\/FNANA.2017.00127\/BIBTEX","DOI":"10.3389\/FNANA.2017.00127\/BIBTEX"},{"key":"2130_CR17","doi-asserted-by":"publisher","first-page":"14204","DOI":"10.1523\/JNEUROSCI.3285-11.2011","volume":"31","author":"R Noseda","year":"2011","unstructured":"Noseda R, Jakubowski M, Kainz V et al (2011) Cortical Projections of Functionally Identified Thalamic Trigeminovascular Neurons: Implications for Migraine Headache and Its Associated Symptoms. The Journal of Neuroscience 31:14204. https:\/\/doi.org\/10.1523\/JNEUROSCI.3285-11.2011","journal-title":"The Journal of Neuroscience"},{"key":"2130_CR18","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1152\/JN.00029.2002","volume":"88","author":"D Levy","year":"2002","unstructured":"Levy D, Strassman AM (2002) Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura. J Neurophysiol 88:3021\u20133031. https:\/\/doi.org\/10.1152\/JN.00029.2002","journal-title":"J Neurophysiol"},{"key":"2130_CR19","doi-asserted-by":"publisher","unstructured":"Benemei S, Dussor G (2019) TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities. Pharmaceuticals (Basel) 12. https:\/\/doi.org\/10.3390\/PH12020054","DOI":"10.3390\/PH12020054"},{"key":"2130_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/J.NEUROPHARM.2019.02.015","volume":"149","author":"N Mikhailov","year":"2019","unstructured":"Mikhailov N, Leskinen J, Fagerlund I et al (2019) Mechanosensitive meningeal nociception via Piezo channels: Implications for pulsatile pain in migraine? Neuropharmacology 149:113\u2013123. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2019.02.015","journal-title":"Neuropharmacology"},{"key":"2130_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/384560a0","author":"AM Strassman","year":"1996","unstructured":"Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature. https:\/\/doi.org\/10.1038\/384560a0","journal-title":"Nature"},{"key":"2130_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1124\/jpet.107.123745","volume":"322","author":"XC Zhang","year":"2007","unstructured":"Zhang XC, Strassman AM, Burstein R, Levy D (2007) Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. Journal of Pharmacology and Experimental Therapeutics 322:806\u2013812. https:\/\/doi.org\/10.1124\/jpet.107.123745","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"2130_CR23","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1152\/JN.1998.79.2.964","volume":"79","author":"R Burstein","year":"1998","unstructured":"Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964\u2013982. https:\/\/doi.org\/10.1152\/JN.1998.79.2.964","journal-title":"J Neurophysiol"},{"key":"2130_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/J.1526-4610.1995.HED3509520.X","volume":"35","author":"M Lamonte","year":"1995","unstructured":"Lamonte M, Silberstein SD, Marcelis JF (1995) Headache associated with aseptic meningitis. Headache 35:520\u2013526. https:\/\/doi.org\/10.1111\/J.1526-4610.1995.HED3509520.X","journal-title":"Headache"},{"key":"2130_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/BRAIN\/AWY005","volume":"141","author":"D Fontaine","year":"2018","unstructured":"Fontaine D, Almairac F, Santucci S et al (2018) Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies. Brain 141:1040\u20131048. https:\/\/doi.org\/10.1093\/BRAIN\/AWY005","journal-title":"Brain"},{"key":"2130_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/01.STR.21.4.555","volume":"21","author":"FT Nichols","year":"1990","unstructured":"Nichols FT, Mawad M, Mohr JP et al (1990) Focal headache during balloon inflation in the internal carotid and middle cerebral arteries. Stroke 21:555\u2013559. https:\/\/doi.org\/10.1161\/01.STR.21.4.555","journal-title":"Stroke"},{"key":"2130_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/BRAIN\/60.4.389","volume":"60","author":"W Penfield","year":"1937","unstructured":"Penfield W, Boldrey E (1937) Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain 60:389\u2013443. https:\/\/doi.org\/10.1093\/BRAIN\/60.4.389","journal-title":"Brain"},{"key":"2130_CR28","doi-asserted-by":"publisher","unstructured":"Della Pietra A, G\u00f3mez Dab\u00f3 L, Mikulenka P et al (2024) Mechanosensitive receptors in migraine: a systematic review. Journal of Headache and Pain 25(1):6. https:\/\/doi.org\/10.1186\/S10194-023-01710-1","DOI":"10.1186\/S10194-023-01710-1"},{"key":"2130_CR29","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/0333102417720216","volume":"38","author":"DM LaPaglia","year":"2018","unstructured":"LaPaglia DM, Sapio MR, Burbelo PD et al (2018) RNA-Seq investigations of human post-mortem trigeminal ganglia. Cephalalgia 38:912\u2013932. https:\/\/doi.org\/10.1177\/0333102417720216","journal-title":"Cephalalgia"},{"key":"2130_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/SCIENCE.1193270","volume":"330","author":"B Coste","year":"2010","unstructured":"Coste B, Mathur J, Schmidt M et al (2010) Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science 330:55\u201360. https:\/\/doi.org\/10.1126\/SCIENCE.1193270","journal-title":"Science"},{"key":"2130_CR31","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1523\/JNEUROSCI.0350-22.2022","volume":"42","author":"S Belin","year":"2022","unstructured":"Belin S, Maki BA, Catlin J et al (2022) Membrane Stretch Gates NMDA Receptors. Journal of Neuroscience 42:5672\u20135680. https:\/\/doi.org\/10.1523\/JNEUROSCI.0350-22.2022","journal-title":"Journal of Neuroscience"},{"key":"2130_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/BJP.2008.86","volume":"154","author":"KB Ploug","year":"2008","unstructured":"Ploug KB, Boni LJ, Baun M et al (2008) K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries. Br J Pharmacol 154:72\u201381. https:\/\/doi.org\/10.1038\/BJP.2008.86","journal-title":"Br J Pharmacol"},{"key":"2130_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/BS.IRN.2016.03.017","volume":"128","author":"G Krishnamoorthy-Natarajan","year":"2016","unstructured":"Krishnamoorthy-Natarajan G, Koide M (2016) BK Channels in the Vascular System. Int Rev Neurobiol 128:401\u2013438. https:\/\/doi.org\/10.1016\/BS.IRN.2016.03.017","journal-title":"Int Rev Neurobiol"},{"key":"2130_CR34","doi-asserted-by":"publisher","unstructured":"Rienecker KDA, Poston RG, Saha RN (2020) Merits and Limitations of Studying Neuronal Depolarization-Dependent Processes Using Elevated External Potassium. ASN Neuro 12:1-17. https:\/\/doi.org\/10.1177\/1759091420974807","DOI":"10.1177\/1759091420974807"},{"key":"2130_CR35","doi-asserted-by":"crossref","unstructured":"Christensen RH, Strassman A, Ashina M, et al (2025) Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache. Cephalalgia 45(8):3331024251359237.","DOI":"10.1177\/03331024251359237"},{"key":"2130_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/brain\/awz199","volume":"1","author":"MA Al-Karagholi","year":"2019","unstructured":"Al-Karagholi MA, Hansen JM, Guo S et al (2019) Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain 1:11. https:\/\/doi.org\/10.1093\/brain\/awz199","journal-title":"Brain"},{"key":"2130_CR37","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1097\/J.PAIN.0000000000002238","volume":"162","author":"MA Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA, Ghanizada H, Waldorff Nielsen CA et al (2021) Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine. Pain 162:2512\u20132520. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000002238","journal-title":"Pain"},{"key":"2130_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/03331024211053570","volume":"42","author":"SL Christensen","year":"2022","unstructured":"Christensen SL, Rasmussen RH, La Cour S et al (2022) Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models. Cephalalgia 42:93\u2013107. https:\/\/doi.org\/10.1177\/03331024211053570","journal-title":"Cephalalgia"},{"key":"2130_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1113\/EXPPHYSIOL.2007.038588","volume":"93","author":"JA Mitchell","year":"2008","unstructured":"Mitchell JA, Ali F, Bailey L et al (2008) Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol 93:141\u2013147. https:\/\/doi.org\/10.1113\/EXPPHYSIOL.2007.038588","journal-title":"Exp Physiol"},{"key":"2130_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1161\/01.RES.77.2.274","volume":"77","author":"ST Davidge","year":"1995","unstructured":"Davidge ST, Baker PN, McLaughlin MK, Roberts JM (1995) Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77:274\u2013283. https:\/\/doi.org\/10.1161\/01.RES.77.2.274","journal-title":"Circ Res"},{"key":"2130_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1468-1331.1994.tb00053.x","volume":"1","author":"LL Thomsen","year":"1994","unstructured":"Thomsen LL, Kruuse C, Iversen HK, Olesen J (1994) A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1:73\u201380. https:\/\/doi.org\/10.1111\/j.1468-1331.1994.tb00053.x","journal-title":"Eur J Neurol"},{"key":"2130_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1468-2982.2009.01923.x","volume":"30","author":"T Wienecke","year":"2010","unstructured":"Wienecke T, Olesen J, Ashina M (2010) Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia 30:179\u2013190. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01923.x","journal-title":"Cephalalgia"},{"key":"2130_CR43","doi-asserted-by":"publisher","unstructured":"Antonova M, Wienecke T, Olesen J, Ashina M (2012) Prostaglandin E (2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia 32(11):822-833. https:\/\/doi.org\/10.1186\/1129-2377-14-s1-p113","DOI":"10.1186\/1129-2377-14-s1-p113"},{"key":"2130_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/J.1468-2982.1988.0802083.X","volume":"8","author":"S Markowitz","year":"1988","unstructured":"Markowitz S, Saito K, Moskowitz MA (1988) Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 8:83\u201391. https:\/\/doi.org\/10.1046\/J.1468-2982.1988.0802083.X","journal-title":"Cephalalgia"},{"key":"2130_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/308653A0","volume":"308","author":"RT Mason","year":"1984","unstructured":"Mason RT, Peterfreund RA, Sawchenko PE et al (1984) Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells. Nature 308:653\u2013655. https:\/\/doi.org\/10.1038\/308653A0","journal-title":"Nature"},{"key":"2130_CR46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/0306-4522(83)90269-5","volume":"9","author":"MA Moskowitz","year":"1983","unstructured":"Moskowitz MA, Brody M, Liu-Chen LY (1983) In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 9:809\u2013814. https:\/\/doi.org\/10.1016\/0306-4522(83)90269-5","journal-title":"Neuroscience"},{"key":"2130_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0333102412439354","volume":"32","author":"M Baun","year":"2012","unstructured":"Baun M, Pedersen MHF, Olesen J, Jansen-Olesen I (2012) Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 32:337\u2013345. https:\/\/doi.org\/10.1177\/0333102412439354","journal-title":"Cephalalgia"},{"key":"2130_CR48","doi-asserted-by":"publisher","first-page":"874193","DOI":"10.3389\/FNEUR.2022.874193","volume":"13","author":"LK Balcziak","year":"2022","unstructured":"Balcziak LK, Russo AF (2022) Dural Immune Cells, CGRP, and Migraine. Front Neurol 13:874193. https:\/\/doi.org\/10.3389\/FNEUR.2022.874193","journal-title":"Front Neurol"},{"key":"2130_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-5728(96)00132-4","volume":"71","author":"WZ Ho","year":"1996","unstructured":"Ho WZ, Kaufman D, Uvaydova M, Douglas SD (1996) Substance P augments interleukin-10 and tumor necrosis factor-\u03b1 release by human cord blood monocytes and macrophages. J Neuroimmunol 71:73\u201380. https:\/\/doi.org\/10.1016\/S0165-5728(96)00132-4","journal-title":"J Neuroimmunol"},{"key":"2130_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/J.CELLSIG.2005.03.027","volume":"18","author":"N El Zein","year":"2006","unstructured":"El Zein N, Corazza F, Sariban E (2006) The neuropeptide pituitary adenylate cyclase activating protein is a physiological activator of human monocytes. Cell Signal 18:162\u2013173. https:\/\/doi.org\/10.1016\/J.CELLSIG.2005.03.027","journal-title":"Cell Signal"},{"key":"2130_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T et al (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16\u201325. https:\/\/doi.org\/10.1093\/brain\/awn307","journal-title":"Brain"},{"key":"2130_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","volume":"13","author":"M Ashina","year":"2017","unstructured":"Ashina M, Hansen JM, \u00e1 Dunga BO, Olesen J (2017) Human models of migraine \u2014 short-term pain for long-term gain. Nat Rev Neurol 13:713\u2013724. https:\/\/doi.org\/10.1038\/nrneurol.2017.137","journal-title":"Nat Rev Neurol"},{"key":"2130_CR53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/J.1468-2982.2006.01257.X","volume":"27","author":"JM Hansen","year":"2007","unstructured":"Hansen JM, Pedersen DL, Larsen VA et al (2007) Magnetic resonance angiography shows dilatation of the middle cerebral artery after infusion of glyceryl trinitrate in healthy volunteers. Cephalalgia 27:118\u2013127. https:\/\/doi.org\/10.1111\/J.1468-2982.2006.01257.X","journal-title":"Cephalalgia"},{"key":"2130_CR54","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1212\/WNL.0b013e3181f9626a","volume":"75","author":"MS Asghar","year":"2010","unstructured":"Asghar MS, Hansen AE, Kapijimpanga T et al (2010) Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology 75:1520\u20131526. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f9626a","journal-title":"Neurology"},{"key":"2130_CR55","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/0333102418787336","volume":"0","author":"CE Christensen","year":"2018","unstructured":"Christensen CE, Amin FM, Younis S et al (2018) Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers. Cephalalgia 0:264\u2013273. https:\/\/doi.org\/10.1177\/0333102418787336","journal-title":"Cephalalgia"},{"key":"2130_CR56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","volume":"137","author":"FM Amin","year":"2014","unstructured":"Amin FM, Hougaard A, Schytz HW et al (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 137:779\u2013794. https:\/\/doi.org\/10.1093\/brain\/awt369","journal-title":"Brain"},{"key":"2130_CR57","doi-asserted-by":"publisher","first-page":"170134","DOI":"10.1016\/j.peptides.2019.170134","volume":"121","author":"H Ghanizada","year":"2019","unstructured":"Ghanizada H, Al-Mahdi Al-Karagholi M, Arngrim N et al (2019) Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: a 3T MRI study. Peptides (NY) 121:170134. https:\/\/doi.org\/10.1016\/j.peptides.2019.170134","journal-title":"Peptides (NY)"},{"key":"2130_CR58","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1177\/0333102420937655","volume":"40","author":"L Pellesi","year":"2020","unstructured":"Pellesi L, Al-Karagholi MAM, Chaudhry BA et al (2020) Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers. Cephalalgia 40:1212\u20131223. https:\/\/doi.org\/10.1177\/0333102420937655","journal-title":"Cephalalgia"},{"key":"2130_CR59","doi-asserted-by":"publisher","unstructured":"Al-Karagholi MA-M, Ghanizada H, Hansen JM et al (2019) Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Arteries. Cerebral. Headache 1468\u20131480. https:\/\/doi.org\/10.1111\/head.13634","DOI":"10.1111\/head.13634"},{"key":"2130_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/BRAIN\/AWY300","volume":"142","author":"S Khan","year":"2019","unstructured":"Khan S, Amin FM, Christensen CE et al (2019) Meningeal contribution to migraine pain: a magnetic resonance angiography study. Brain 142:93\u2013102. https:\/\/doi.org\/10.1093\/BRAIN\/AWY300","journal-title":"Brain"},{"key":"2130_CR61","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1177\/0333102419888490\/ASSET\/IMAGES\/LARGE\/10.1177_0333102419888490-FIG7.JPEG","volume":"39","author":"MAM Al-Karagholi","year":"2019","unstructured":"Al-Karagholi MAM, Ghanizada H, Hansen JM et al (2019) Extracranial activation of ATP-sensitive potassium channels induces vasodilation without nociceptive effects. Cephalalgia 39:1789\u20131797. https:\/\/doi.org\/10.1177\/0333102419888490\/ASSET\/IMAGES\/LARGE\/10.1177_0333102419888490-FIG7.JPEG","journal-title":"Cephalalgia"},{"key":"2130_CR62","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0196-9781(91)90022-H","volume":"12","author":"U Pedersen-Bjergaard","year":"1991","unstructured":"Pedersen-Bjergaard U, Nielsen LB, Jensen K et al (1991) Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides (NY) 12:333\u2013337. https:\/\/doi.org\/10.1016\/0196-9781(91)90022-H","journal-title":"Peptides (NY)"},{"key":"2130_CR63","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0306-4522(03)00069-1","volume":"118","author":"W Xu","year":"2003","unstructured":"Xu W, Lundeberg T, Wang YT et al (2003) Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: Activating opioid receptors through amygdala-periaqueductal gray pathway. Neuroscience 118:1015\u20131022. https:\/\/doi.org\/10.1016\/S0306-4522(03)00069-1","journal-title":"Neuroscience"},{"key":"2130_CR64","doi-asserted-by":"publisher","unstructured":"Schr\u00f6r K (2002) The pharmacology of cilostazol. Diabetes Obes Metab 4 Suppl 2: S14-S19 https:\/\/doi.org\/10.1046\/J.1463-1326.2002.0040S2S14.X","DOI":"10.1046\/J.1463-1326.2002.0040S2S14.X"},{"key":"2130_CR65","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/J.NEUROPHARM.2006.07.017","volume":"51","author":"L Dickson","year":"2006","unstructured":"Dickson L, Aramori I, McCulloch J et al (2006) A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC\/PAC receptor pharmacology. Neuropharmacology 51:1086\u20131098. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2006.07.017","journal-title":"Neuropharmacology"},{"key":"2130_CR66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1046\/J.1468-2982.1996.1605310.X","volume":"16","author":"I Jansen-Olesen","year":"1996","unstructured":"Jansen-Olesen I, Mortensen A, Edvinsson L (1996) Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia 16:310\u2013316. https:\/\/doi.org\/10.1046\/J.1468-2982.1996.1605310.X","journal-title":"Cephalalgia"},{"key":"2130_CR67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/J.1469-7793.1998.117BU.X","volume":"507","author":"GC Wellman","year":"1998","unstructured":"Wellman GC, Quayle JM, Standen NB (1998) ATP-sensitive K + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 507:117. https:\/\/doi.org\/10.1111\/J.1469-7793.1998.117BU.X","journal-title":"J Physiol"},{"key":"2130_CR68","doi-asserted-by":"publisher","unstructured":"Armstead WM (1996) Role of ATP-sensitive K\u2009+\u2009channels in cGMP-mediated pial artery vasodilation. Am J Physiol 270:H423-6. https:\/\/doi.org\/10.1152\/AJPHEART.1996.270.2.H423","DOI":"10.1152\/AJPHEART.1996.270.2.H423"},{"key":"2130_CR69","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/J.1527-3466.2001.TB00076.X","volume":"19","author":"Y Liu","year":"2001","unstructured":"Liu Y, Shakur Y, Yoshitake M, Kambayashi JI (2001) Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovasc Drug Rev 19:369\u2013386. https:\/\/doi.org\/10.1111\/J.1527-3466.2001.TB00076.X","journal-title":"Cardiovasc Drug Rev"},{"key":"2130_CR70","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1046\/J.1464-410X.1997.00206.X","volume":"79","author":"JY Jeremy","year":"1997","unstructured":"Jeremy JY, Ballard SA, Naylor AM et al (1997) Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 79:958\u2013963. https:\/\/doi.org\/10.1046\/J.1464-410X.1997.00206.X","journal-title":"Br J Urol"},{"key":"2130_CR71","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/BRAIN\/AWAB136","volume":"144","author":"MA Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA, Ghanizada H, Nielsen CAW et al (2021) Opening of ATP sensitive potassium channels causes migraine attacks with aura. Brain 144:2322\u20132332. https:\/\/doi.org\/10.1093\/BRAIN\/AWAB136","journal-title":"Brain"},{"key":"2130_CR72","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54\u201361. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00310.x","journal-title":"Cephalalgia"},{"key":"2130_CR73","doi-asserted-by":"publisher","unstructured":"Al-Khazali HM, Ashina H, Christensen RH, et al (2024) Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab. Cephalalgia 44(6):3331024241258734. https:\/\/doi.org\/10.1177\/03331024241258734","DOI":"10.1177\/03331024241258734"},{"key":"2130_CR74","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","volume":"157","author":"S Guo","year":"2016","unstructured":"Guo S, Vollesen ALH, Olesen J, Ashina M (2016) Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine. Pain 157:2773\u20132781. https:\/\/doi.org\/10.1097\/j.pain.0000000000000702","journal-title":"Pain"},{"key":"2130_CR75","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1093\/BRAIN\/AWAD261","volume":"146","author":"TP Do","year":"2023","unstructured":"Do TP, Deligianni C, Amirguliyev S et al (2023) Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans. Brain 146:5224\u20135234. https:\/\/doi.org\/10.1093\/BRAIN\/AWAD261","journal-title":"Brain"},{"key":"2130_CR76","doi-asserted-by":"publisher","unstructured":"Raffaelli B, Do TP, Ashina H, et al (2024) Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation. Cephalalgia 44(6):3331024241259489. https:\/\/doi.org\/10.1177\/03331024241259489","DOI":"10.1177\/03331024241259489"},{"key":"2130_CR77","doi-asserted-by":"publisher","unstructured":"Raffaelli B, Do TP, Chaudhry BA, et al (2024) Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial. Cephalalgia 44(1):3331024231222916. https:\/\/doi.org\/10.1177\/03331024231222916","DOI":"10.1177\/03331024231222916"},{"key":"2130_CR78","doi-asserted-by":"publisher","unstructured":"Ashina S, Robertson CE, Srikiatkhachorn A, et al (2024) Trigeminal neuralgia. Nat Rev Dis Primers 10(1):39. https:\/\/doi.org\/10.1038\/S41572-024-00523-Z","DOI":"10.1038\/S41572-024-00523-Z"},{"key":"2130_CR79","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(22)00294-0","volume":"21","author":"AS Schott Andersen","year":"2022","unstructured":"Schott Andersen AS, Maarbjerg S, Noory N et al (2022) Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study. Lancet Neurol 21:994\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(22)00294-0","journal-title":"Lancet Neurol"},{"key":"2130_CR80","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-2999(00)00355-1","volume":"400","author":"AC Soares","year":"2000","unstructured":"Soares AC, Leite R, Tatsuo MAKF, Duarte IDG (2000) Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur J Pharmacol 400:67\u201371. https:\/\/doi.org\/10.1016\/S0014-2999(00)00355-1","journal-title":"Eur J Pharmacol"},{"key":"2130_CR81","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0014-2999(90)90466-J","volume":"186","author":"M Oca\u00f1a","year":"1990","unstructured":"Oca\u00f1a M, Del Pozo E, Barrios M et al (1990) An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 186:377\u2013378. https:\/\/doi.org\/10.1016\/0014-2999(90)90466-J","journal-title":"Eur J Pharmacol"},{"key":"2130_CR82","doi-asserted-by":"publisher","unstructured":"Du X, Wang C, Zhang H (2011) Activation of ATP-sensitive potassium channels antagonize nociceptive behavior and hyperexcitability of DRG neurons from rats. Mol Pain 7. https:\/\/doi.org\/10.1186\/1744-8069-7-35","DOI":"10.1186\/1744-8069-7-35"},{"key":"2130_CR83","doi-asserted-by":"publisher","unstructured":"Kokoti L, Al-Karagholi MAM, Zhuang ZA et al (2024) Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial. Cephalalgia 44. https:\/\/doi.org\/10.1177\/03331024241248211","DOI":"10.1177\/03331024241248211"},{"key":"2130_CR84","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/J.1468-2982.2007.01497.X","volume":"28","author":"A Rahmann","year":"2008","unstructured":"Rahmann A, Wienecke T, Hansen JM et al (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226\u2013236. https:\/\/doi.org\/10.1111\/J.1468-2982.2007.01497.X","journal-title":"Cephalalgia"},{"key":"2130_CR85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0196-9781(99)00177-1","volume":"21","author":"N Tun\u00e7el","year":"2000","unstructured":"Tun\u00e7el N, T\u00f6re F, Sahint\u00fcrk V et al (2000) Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: A potential therapeutic strategy in controlling septic shock. Peptides (NY) 21:81\u201389. https:\/\/doi.org\/10.1016\/S0196-9781(99)00177-1","journal-title":"Peptides (NY)"},{"key":"2130_CR86","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/0333102420975395","volume":"41","author":"N Katarina Frifelt Wienholtz","year":"2021","unstructured":"Katarina Frifelt Wienholtz N, Emil Christensen C, Georgina Zhang D et al (2021) Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial. Cephalalgia 41:731\u2013748. https:\/\/doi.org\/10.1177\/0333102420975395","journal-title":"Cephalalgia"},{"key":"2130_CR87","doi-asserted-by":"publisher","unstructured":"Christensen RH, Strassman A, Ashina M, et al (2025) Activation and sensitization of meningeal nocic eptors by PACAP-38: implications for migraine headache. Brain (in press). https:\/\/doi.org\/10.1093\/brain\/awaf284","DOI":"10.1093\/brain\/awaf284"},{"key":"2130_CR88","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S1474-4422(13)70067-X","volume":"12","author":"FM Amin","year":"2013","unstructured":"Amin FM, Asghar MS, Hougaard A et al (2013) Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: A cross-sectional study. Lancet Neurol 12:454\u2013461. https:\/\/doi.org\/10.1016\/S1474-4422(13)70067-X","journal-title":"Lancet Neurol"},{"key":"2130_CR89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/J.1468-2982.1995.015002109.X","volume":"15","author":"L Thomsen","year":"1995","unstructured":"Thomsen L, Iversen H, Olesen J (1995) Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia 15:109\u2013116. https:\/\/doi.org\/10.1046\/J.1468-2982.1995.015002109.X","journal-title":"Cephalalgia"},{"key":"2130_CR90","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.22292","volume":"69","author":"MS Asghar","year":"2011","unstructured":"Asghar MS, Hansen AE, Amin FM et al (2011) Evidence for a vascular factor in migraine. Ann Neurol 69:635\u2013645. https:\/\/doi.org\/10.1002\/ana.22292","journal-title":"Ann Neurol"},{"key":"2130_CR91","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/brain\/awn094","volume":"131","author":"GG Schoonman","year":"2008","unstructured":"Schoonman GG, Van Der Grond J, Kortmann C et al (2008) Migraine headache is not associated with cerebral or meningeal vasodilatation - A 3T magnetic resonance angiography study. Brain 131:2192\u20132200. https:\/\/doi.org\/10.1093\/brain\/awn094","journal-title":"Brain"},{"key":"2130_CR92","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/J.1468-2982.1994.1406401.X","volume":"14","author":"PPA Humphrey","year":"1994","unstructured":"Humphrey PPA, Goadsby PJ (1994) The mode of action of sumatriptan is vascular? A debate. Cephalalgia 14:401\u2013410. https:\/\/doi.org\/10.1046\/J.1468-2982.1994.1406401.X","journal-title":"Cephalalgia"},{"key":"2130_CR93","doi-asserted-by":"publisher","unstructured":"Karlsson WK, Ostinelli EG, Zhuang ZA et al (2024) Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis. BMJ 386. https:\/\/doi.org\/10.1136\/BMJ-2024-080107","DOI":"10.1136\/BMJ-2024-080107"},{"key":"2130_CR94","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/187152412803760627","volume":"12","author":"D D Mitsikostas","year":"2012","unstructured":"D Mitsikostas D, Tfelt-Hansen P (2012) Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future. Cent Nerv Syst Agents Med Chem 12:241\u2013249. https:\/\/doi.org\/10.2174\/187152412803760627","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2130_CR95","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1474-4422(17)30083-2","volume":"16","author":"S Tepper","year":"2017","unstructured":"Tepper S, Ashina M, Reuter U et al (2017) Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 16:425\u2013434. https:\/\/doi.org\/10.1016\/S1474-4422(17)30083-2","journal-title":"Lancet Neurol"},{"key":"2130_CR96","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMOA1811090","volume":"381","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Croop R, Stock EG et al (2019) Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine. N Engl J Med 381:142\u2013149. https:\/\/doi.org\/10.1056\/NEJMOA1811090","journal-title":"N Engl J Med"},{"key":"2130_CR97","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","volume":"397","author":"R Croop","year":"2021","unstructured":"Croop R, Lipton RB, Kudrow D et al (2021) Oral rimegepant for preventive treatment of migraine: a phase 2\/3, randomised, double-blind, placebo-controlled trial. Lancet 397:51\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(20)32544-7","journal-title":"Lancet"},{"key":"2130_CR98","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMOA2314577","volume":"391","author":"M Ashina","year":"2024","unstructured":"Ashina M, Phul R, Khodaie M et al (2024) A Monoclonal Antibody to PACAP for Migraine Prevention. N Engl J Med 391:800\u2013809. https:\/\/doi.org\/10.1056\/NEJMOA2314577","journal-title":"N Engl J Med"},{"key":"2130_CR99","doi-asserted-by":"publisher","unstructured":"Rasmussen NB, Deligianni C, Christensen CE et al (2023) The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study. J Headache Pain 24. https:\/\/doi.org\/10.1186\/S10194-023-01599-W","DOI":"10.1186\/S10194-023-01599-W"},{"key":"2130_CR100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/0333102420970889","volume":"41","author":"M Ashina","year":"2021","unstructured":"Ashina M, Dole\u017eil D, Bonner JH et al (2021) A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. Cephalalgia 41:33\u201344. https:\/\/doi.org\/10.1177\/0333102420970889","journal-title":"Cephalalgia"},{"key":"2130_CR101","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/J.NURT.2010.02.004","volume":"7","author":"L Edvinsson","year":"2010","unstructured":"Edvinsson L, Ho TW (2010) CGRP receptor antagonism and migraine. Neurotherapeutics 7:164\u2013175. https:\/\/doi.org\/10.1016\/J.NURT.2010.02.004","journal-title":"Neurotherapeutics"},{"key":"2130_CR102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0333102419896760","volume":"40","author":"R Noseda","year":"2020","unstructured":"Noseda R, Schain AJ, Melo-Carrillo A et al (2020) Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia 40:229\u2013240. https:\/\/doi.org\/10.1177\/0333102419896760","journal-title":"Cephalalgia"},{"key":"2130_CR103","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1152\/PHYSREV.00027.2014\/ASSET\/IMAGES\/LARGE\/Z9J0031527390010.JPEG","volume":"95","author":"C Ayata","year":"2015","unstructured":"Ayata C, Lauritzen M (2015) Spreading depression, spreading depolarizations, and the cerebral vasculature. Physiol Rev 95:953\u2013993. https:\/\/doi.org\/10.1152\/PHYSREV.00027.2014\/ASSET\/IMAGES\/LARGE\/Z9J0031527390010.JPEG","journal-title":"Physiol Rev"},{"key":"2130_CR104","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","volume":"30","author":"XC Zhang","year":"2010","unstructured":"Zhang XC, Levy D, Noseda R et al (2010) Neurobiology of Disease Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura. Journal of Neuroscience 30:8807\u20138814. https:\/\/doi.org\/10.1523\/JNEUROSCI.0511-10.2010","journal-title":"Journal of Neuroscience"},{"key":"2130_CR105","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1233321","volume":"339","author":"H Karatas","year":"1979","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y et al (1979) (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339:1092\u20135. https:\/\/doi.org\/10.1126\/science.1233321","journal-title":"Science"},{"key":"2130_CR106","doi-asserted-by":"publisher","unstructured":"Al-Khazali HM, Ashina H, Wiggers A et al (2023) Calcitonin gene-related peptide causes migraine aura. J Headache Pain 24. https:\/\/doi.org\/10.1186\/S10194-023-01656-4","DOI":"10.1186\/S10194-023-01656-4"},{"key":"2130_CR107","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1152\/JAPPLPHYSIOL.01095.2005","volume":"101","author":"DN Krause","year":"2006","unstructured":"Krause DN, Duckles SP, Pelligrino DA (2006) Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 101:1252\u20131261. https:\/\/doi.org\/10.1152\/JAPPLPHYSIOL.01095.2005","journal-title":"J Appl Physiol"},{"key":"2130_CR108","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ANA.21994","volume":"68","author":"R Burstein","year":"2010","unstructured":"Burstein R, Jakubowski M, Garcia-Nicas E et al (2010) Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol 68:81. https:\/\/doi.org\/10.1002\/ANA.21994","journal-title":"Ann Neurol"},{"key":"2130_CR109","doi-asserted-by":"publisher","unstructured":"Karsan N, Goadsby PJ (2025) Vasoneuronal signalling plays a causal role in migraine pathogenesis: the \u2018Con\u2019 argument. J Headache Pain 26. https:\/\/doi.org\/10.1186\/s10194-025-02131-y","DOI":"10.1186\/s10194-025-02131-y"},{"key":"2130_CR110","doi-asserted-by":"publisher","unstructured":"Eigenbrodt AK, Christensen RH, Ashina H et al (2022) Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency. J Headache Pain 23. https:\/\/doi.org\/10.1186\/S10194-022-01510-Z","DOI":"10.1186\/S10194-022-01510-Z"},{"key":"2130_CR111","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/J.1468-2982.2005.00880.X","volume":"25","author":"N Karli","year":"2005","unstructured":"Karli N, Zarifoglu M, Calisir N, Akgoz S (2005) Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: Do they share similar clinical pathophysiology? Cephalalgia 25:444\u2013451. https:\/\/doi.org\/10.1111\/J.1468-2982.2005.00880.X","journal-title":"Cephalalgia"},{"key":"2130_CR112","doi-asserted-by":"publisher","first-page":"1192121","DOI":"10.3389\/FPUBH.2023.1192121\/FULL","volume":"11","author":"JH Yoon","year":"2023","unstructured":"Yoon JH, Park NH, Kang YE et al (2023) The demographic features of fatigue in the general population worldwide: a systematic review and meta-analysis. Front Public Health 11:1192121. https:\/\/doi.org\/10.3389\/FPUBH.2023.1192121\/FULL","journal-title":"Front Public Health"},{"key":"2130_CR113","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0031-9384(95)02014-4","volume":"59","author":"R Baenninger","year":"1996","unstructured":"Baenninger R, Binkley S, Baenninger M (1996) Field observations of yawning and activity in humans. Physiol Behav 59:421\u2013425. https:\/\/doi.org\/10.1016\/0031-9384(95)02014-4","journal-title":"Physiol Behav"},{"key":"2130_CR114","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/S10164-010-0242-0\/METRICS","volume":"29","author":"F Giganti","year":"2011","unstructured":"Giganti F, Zilli I (2011) The daily time course of contagious and spontaneous yawning among humans. J Ethol 29:215\u2013219. https:\/\/doi.org\/10.1007\/S10164-010-0242-0\/METRICS","journal-title":"J Ethol"},{"key":"2130_CR115","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1212\/WNL.0000000000002789","volume":"87","author":"NJ Giffin","year":"2016","unstructured":"Giffin NJ, Lipton RB, Silberstein SD et al (2016) The migraine postdrome: An electronic diary study. Neurology 87:309\u2013313. https:\/\/doi.org\/10.1212\/WNL.0000000000002789","journal-title":"Neurology"},{"key":"2130_CR116","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2147\/JPR.S175602","volume":"11","author":"AB Gago-Veiga","year":"2018","unstructured":"Gago-Veiga AB, Pag\u00e1n J, Henares K et al (2018) To what extent are patients with migraine able to predict attacks? J Pain Res 11:2083\u20132094. https:\/\/doi.org\/10.2147\/JPR.S175602","journal-title":"J Pain Res"},{"key":"2130_CR117","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jcv.2017.07.016","volume":"94","author":"B Shukla","year":"2017","unstructured":"Shukla B, Aguilera EA, Salazar L et al (2017) Aseptic meningitis in adults and children: Diagnostic and management challenges. Journal of Clinical Virology 94:110\u2013114. https:\/\/doi.org\/10.1016\/j.jcv.2017.07.016","journal-title":"Journal of Clinical Virology"},{"key":"2130_CR118","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1227\/01.NEU.0000306090.30517.AE","volume":"61","author":"AM Shea","year":"2007","unstructured":"Shea AM, Reed SD, Curtis LH et al (2007) Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery 61:1131\u20131137. https:\/\/doi.org\/10.1227\/01.NEU.0000306090.30517.AE","journal-title":"Neurosurgery"},{"key":"2130_CR119","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMCP1605827","volume":"377","author":"CG Solomon","year":"2017","unstructured":"Solomon CG, Lawton MT, Vates GE (2017) Subarachnoid Hemorrhage. N Engl J Med 377:257\u201366. https:\/\/doi.org\/10.1056\/NEJMCP1605827","journal-title":"N Engl J Med"},{"key":"2130_CR120","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1152\/PHYSREV.00025.2008\/ASSET\/IMAGES\/LARGE\/Z9J0020925080004.JPEG","volume":"89","author":"J Sandk\u00fchler","year":"2009","unstructured":"Sandk\u00fchler J (2009) Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 89:707\u2013758. https:\/\/doi.org\/10.1152\/PHYSREV.00025.2008\/ASSET\/IMAGES\/LARGE\/Z9J0020925080004.JPEG","journal-title":"Physiol Rev"},{"key":"2130_CR121","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/BRAIN\/122.12.2245","volume":"122","author":"EA Ziegler","year":"1999","unstructured":"Ziegler EA, Magerl W, Meyer RA, Treede RD (1999) Secondary hyperalgesia to punctate mechanical stimuli: Central sensitization to A-fibre nociceptor input. Brain 122:2245\u20132257. https:\/\/doi.org\/10.1093\/BRAIN\/122.12.2245","journal-title":"Brain"},{"key":"2130_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BRAINSCI11020165","volume":"11","author":"D Martinelli","year":"2021","unstructured":"Martinelli D, Castellazzi G, De Icco R et al (2021) Thalamocortical connectivity in experimentally-induced migraine attacks: A pilot study. Brain Sci 11:1\u201316. https:\/\/doi.org\/10.3390\/BRAINSCI11020165","journal-title":"Brain Sci"},{"key":"2130_CR123","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/ENE.12451","volume":"21","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Schankin C, Goadsby PJ (2014) Photic hypersensitivity in the premonitory phase of migraine - a positron emission tomography study. Eur J Neurol 21:1178\u20131183. https:\/\/doi.org\/10.1111\/ENE.12451","journal-title":"Eur J Neurol"},{"key":"2130_CR124","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/HEAD.14538","volume":"63","author":"N Karsan","year":"2023","unstructured":"Karsan N, Bose RP, O\u2019Daly O et al (2023) Regional cerebral perfusion during the premonitory phase of triggered migraine: A double-blind randomized placebo-controlled functional imaging study using pseudo-continuous arterial spin labeling. Headache 63:771\u2013787. https:\/\/doi.org\/10.1111\/HEAD.14538","journal-title":"Headache"},{"key":"2130_CR125","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011930","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Karagholi MA, Arngrim N et al (2021) Effect of Adrenomedullin on Migraine-like Attacks in Patients With Migraine: A Randomized Crossover Study. Neurology 96(20):e2488-e2499. https:\/\/doi.org\/10.1212\/WNL.0000000000011930","journal-title":"Neurology"},{"key":"2130_CR126","doi-asserted-by":"publisher","unstructured":"Ghanizada H, Al-Karagholi MA, Walker CS, et al (2021) Amylin Analog Pramlintide Induces Migraine\u2010like Attacks in Patients. Ann Neurol 89(6):116-1171. https:\/\/doi.org\/10.1002\/ana.26072","DOI":"10.1002\/ana.26072"},{"key":"2130_CR127","doi-asserted-by":"publisher","unstructured":"Pellesi L, Al-Karagholi MA, De Icco R et al (2021) Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial. JAMA Netw Open 4(8):e21185434. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2021.18543","DOI":"10.1001\/JAMANETWORKOPEN.2021.18543"},{"key":"2130_CR128","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","volume":"30","author":"JM Hansen","year":"2010","unstructured":"Hansen JM, Hauge AW, Olesen J, Ashina M (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30:1179\u20131186. https:\/\/doi.org\/10.1177\/0333102410368444","journal-title":"Cephalalgia"},{"key":"2130_CR129","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/HEAD.13753","volume":"60","author":"A Hougaard","year":"2020","unstructured":"Hougaard A, Younis S, Iljazi A et al (2020) Intravenous Endothelin-1 Infusion Does Not Induce Aura or Headache in Migraine Patients With Aura. Headache 60:724\u2013734. https:\/\/doi.org\/10.1111\/HEAD.13753","journal-title":"Headache"},{"key":"2130_CR130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/BCP.12618","volume":"80","author":"L Edvinsson","year":"2015","unstructured":"Edvinsson L (2015) CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol 80:193. https:\/\/doi.org\/10.1111\/BCP.12618","journal-title":"Br J Clin Pharmacol"},{"key":"2130_CR131","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1093\/BRAIN\/AWAE062","volume":"147","author":"A Melo-Carrillo","year":"2024","unstructured":"Melo-Carrillo A, Strassman AM, Broide R et al (2024) Novel insight into atogepant mechanisms of action in migraine prevention. Brain 147:2884\u20132896. https:\/\/doi.org\/10.1093\/BRAIN\/AWAE062","journal-title":"Brain"},{"key":"2130_CR132","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/S41582-023-00842-X","volume":"19","author":"DD Mitsikostas","year":"2023","unstructured":"Mitsikostas DD, Waeber C, Sanchez-del-Rio M et al (2023) The 5-HT1F receptor as the target of ditans in migraine \u2014 from bench to bedside. Nat Rev Neurol 19:489\u2013505. https:\/\/doi.org\/10.1038\/S41582-023-00842-X","journal-title":"Nat Rev Neurol"},{"key":"2130_CR133","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/J.PAIN.0000000000001801","volume":"161","author":"A Labastida-Ram\u00edrez","year":"2020","unstructured":"Labastida-Ram\u00edrez A, Rubio-Beltr\u00e1n E, Haanes KA et al (2020) Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system. Pain 161:1092\u20131099. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000001801","journal-title":"Pain"},{"key":"2130_CR134","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/S0140-6736(23)01683-5","volume":"402","author":"DW Dodick","year":"2023","unstructured":"Dodick DW, Goadsby PJ, Schwedt TJ et al (2023) Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA. The Lancet 402:2307\u20132316. https:\/\/doi.org\/10.1016\/S0140-6736(23)01683-5","journal-title":"The Lancet"},{"key":"2130_CR135","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1124\/JPET.119.261065","volume":"373","author":"E Moore","year":"2020","unstructured":"Moore E, Fraley ME, Bell IM et al (2020) Characterization of ubrogepant: A potent and selective antagonist of the human calcitonin gene-related peptide receptors. Journal of Pharmacology and Experimental Therapeutics 373:160\u2013166. https:\/\/doi.org\/10.1124\/JPET.119.261065","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02130-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:03:15Z","timestamp":1762830195000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02130-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2130"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02130-z","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RHC has received personal fees from Teva, Pfizer, and Lundbeck, outside of the submitted work, has received honoraria from Neurotorium, and serves as section editor for the Journal of Pain Research. HA has received personal fees from AbbVie, Lundbeck, Pfizer, and Teva, outside of the submitted work. HA also serves on the Editorial Board of The Journal of Headache and Pain. MA has received personal fees from AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Lundbeck, Pfizer, and Teva, outside of the submitted work; has received funding from Danish National Research Foundation, Lundbeck Foundation, Novo Nordisk Foundation, Novartis, and Lundbeck; serves as an associate editor for The Journal of Headache and Pain and associate editor for Brain; and serves on the editorial board of Neurotorium and has received honoraria.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}